Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck will delay filing Ebola vaccine for approval until 2018, company confirms

fiercepharmaNovember 22, 2017

Tag: Merck , Ebola , Vaccine

PharmaSources Customer Service